The Psychiatric Genomics Consortium (PGC) is an international consortium of scientists dedicated to conducting meta- and mega-analyses of genomic-wide genetic data, with a focus on psychiatric disorders.
[2] Its goal is to generate information about the genetics of psychiatric conditions that will be "actionable", that is, "genetic findings whose biological implications can be used to improve diagnosis, develop rational therapeutics, and craft mechanistic approaches to primary prevention".
[3] The PGC was founded in early 2007, originally as the Psychiatric Genome Wide Association Consortium.
[2][4] One of its founders was Patrick F. Sullivan (UNC School of Medicine), who now serves as its lead principal investigator.
It also initially focused only on finding common single nucleotide polymorphisms that were associated with psychiatric disorders.